Recordati Industria Chimica e Farmaceutica SPAAz. Post raggruppamento Aktie 2121038 / IT0003828271
40.93
USD
0.53
USD
1.30%
23:20:00
NASO
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen | |||||
Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
FIMEI Finanziaria Industriale Mobiliare ed Immobiliare SpA | 51.82 |
Freefloat | 46.49 |
Mawer Investment Management Ltd. | 5.00 |
Fidelity Management & Research Co. LLC | 3.01 |
Recordati SpA | 1.68 |
Fidelity Series Overseas Fund | 1.56 |
Mawer International Equity Fund | 1.32 |
Mawer Global Equity Fund | 1.05 |
Government Pension Fund - Global (The) | 0.83 |
Fidelity Overseas Fund | 0.82 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|
Personal am Ende des Jahres | 4'142 | 4'323 | 4'362 | 4'303 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.33 | 0.34 | 0.33 | 0.37 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|
Summe Umlaufvermögen | 700 | 809 | 773 | 850 |
Summe Anlagevermögen | 1'752 | 2'299 | 2'337 | 2'374 |
Summe Aktiva | 2'163 | 2'809 | 2'712 | 2'816 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 788 | 1'101 | 1'061 | 992 |
Summe Fremdkapital | 1'200 | 1'610 | 1'435 | 1'435 |
Summe Eigenkapital | 964 | 1'199 | 1'276 | 1'382 |
Summe Passiva | 2'163 | 2'809 | 2'712 | 2'816 |
Adresse
Via Matteo Civitali, 1, 20148 Milan | |
Telefon | +39 (02) 48787-1 |
Fax | +39 (02) 48787225 |
URL | http://www.recordati.it |
Management
Andrea Recordati
Chairman |
Cathrin Petty
Executive Director |
Cédric Ripert
Vice President-Pharmaceuticals International Sales |
Daria Ghidoni
Group General Counsel |
Ezio Maria Simonelli
Principal |
Federica de Medici
Director-Investor Relations & Communications |
Fritz Squindo
Director & Group General Manager |
Gabriele Finzi
Executive VP-Corporate Development & Licensing |
Giampiero Mazza
Executive Director |
Giorgio de Palma
Director |
Giovanni Minora
Head-Group Audit & Compliance |
Giuseppe Gualazzini
Senior Vice President-Group Human Resources |
Guido Guidi
Vice Chairman |
Joanna Susan Le Couilliard
Independent Non-Executive Director |
Kim Stratton
Non-Independent Non-Executive Director |
Luigi Felice la Corte
Group Chief Financial Officer |
Michaela Castelli
Lead Independent Non-Executive Director |
Piergiorgio Peluso
Independent Non-Executive Director |
Raffaele Sabia
Senior VP-Pharmaceutical Research & Development |
Robert Koremans
Chief Executive Officer |
Roberto Teruzzi
Executive VP-Group Industrial Operations |
Witold Urban
VP-Central & Eastern Europe Region |